{
    "2021-02-04": [
        [
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)：控股股东及其一致行动人持股比例降至49.85%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "控股股东",
                        "一致行动人",
                        "持股比例",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：控股股东及其一致行动人持股比例变动超过1%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "控股股东",
                        "一致行动人",
                        "持股比例",
                        "变动"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物现1笔大宗交易 共成交200.75万元",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物今日大宗交易成交1.23万股，成交价163.21元折价9.85%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "大宗交易",
                        "成交价",
                        "折价"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601)：新冠疫苗双线布局 在研管线逐步兑现",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新冠疫苗",
                        "双线布局",
                        "研发管线"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业重大事项点评：第四批带量采购拟中标结果产生 降价幅度符合预期",
                "features": {
                    "keywords": [
                        "医药行业",
                        "带量采购",
                        "中标结果",
                        "降价幅度"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}